Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Abeona Therapeutics Inc. (ABEO) had Stock-Based Compensation of $5.53M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$0.40M |
|
$108.83M |
|
-- |
|
$0.40M |
|
$23.19M |
|
$-22.79M |
|
$147.14M |
|
$124.34M |
|
$124.34M |
|
$108.83M |
|
$108.83M |
|
$108.83M |
|
$108.83M |
|
$-22.79M |
|
$-22.02M |
|
52.52M |
|
66.64M |
|
$2.07 |
|
$1.71 |
|
| Balance Sheet Financials | |
$232.26M |
|
$9.49M |
|
$13.97M |
|
$246.23M |
|
$34.52M |
|
$14.01M |
|
$48.14M |
|
$82.66M |
|
$163.58M |
|
$163.58M |
|
$163.58M |
|
51.25M |
|
| Cash Flow Statement Financials | |
$-37.19M |
|
$160.10M |
|
$17.26M |
|
$23.70M |
|
$163.87M |
|
$140.18M |
|
|
Stock-Based Compensation |
$5.53M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.73 |
|
-- |
|
-- |
|
0.08 |
|
0.12 |
|
100.00% |
|
-5698.00% |
|
-5698.00% |
|
-- |
|
31086.25% |
|
27208.25% |
|
$-41.49M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.25 |
|
366.75 |
|
66.53% |
|
66.53% |
|
44.20% |
|
61.29% |
|
$3.19 |
|
$-0.62 |
|
$-0.56 |
|